Lenalidomide and thalidomide: Mechanisms of action - Similarities and differences

被引：183

作者：

Anderson, KC ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Dana Farber Canc Inst,Div Hematol Neoplasia, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA

来源：

SEMINARS IN HEMATOLOGY | 2005年 / 42卷 / 04期

关键词：

D O I：

10.1053/j.seminhematol.2005.10.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S3 / S8

页数：6

共 18 条

[1] JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cells [J].

Chauhan, D ;

Li, GL ;

Hideshima, T ;

Podar, K ;

Mitsiades, C ;

Mitsiades, N ;

Munshi, N ;

Kharbanda, S ;

Anderson, KC .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (20) :17593-17596

[2] Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B [J].

Chauhan, D ;

Uchiyama, H ;

Akbarali, Y ;

Urashima, M ;

Yamamoto, K ;

Libermann, TA ;

Anderson, KC .

BLOOD, 1996, 87 (03) :1104-1112

[3] Apaf-1/cytochrome c-independent and Smac-dependent induction of apoptosis in multiple myeloma (MM) cells [J].

Chauhan, D ;

Hideshima, T ;

Rosen, S ;

Reed, JC ;

Kharbanda, S ;

Anderson, KC .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (27) :24453-24456

[4] Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma [J].

Davies, FE ;

Raje, N ;

Hideshima, T ;

Lentzsch, S ;

Young, G ;

Tai, YT ;

Lin, B ;

Podar, K ;

Gupta, D ;

Chauhan, D ;

Treon, SP ;

Richardson, PG ;

Schlossman, RL ;

Morgan, GJ ;

Muller, GW ;

Stirling, DI ;

Anderson, KC .

BLOOD, 2001, 98 (01) :210-216

[5] Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications [J].

Gupta, D ;

Treon, SP ;

Shima, Y ;

Hideshima, T ;

Podar, K ;

Tai, YT ;

Lin, B ;

Lentzsch, S ;

Davies, FE ;

Chauhan, D ;

Schlossman, RL ;

Richardson, P ;

Ralph, P ;

Wu, L ;

Payvandi, F ;

Muller, G ;

Stirling, DI ;

Anderson, KC .

LEUKEMIA, 2001, 15 (12) :1950-1961

[6] Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical application [J].

Hayashi, T ;

Hideshima, T ;

Akiyama, M ;

Podar, K ;

Yasui, H ;

Raje, N ;

Kumar, S ;

Chauhan, D ;

Treon, SP ;

Richardson, P ;

Anderson, KC .

BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (02) :192-203

[7]

Hideshima T, 2001, CANCER RES, V61, P3071

[8] Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy [J].

Hideshima, T ;

Chauhan, D ;

Shima, Y ;

Raje, N ;

Davies, FE ;

Tai, YT ;

Treon, SP ;

Lin, B ;

Schlossman, RL ;

Richardson, P ;

Muller, G ;

Stirling, DI ;

Anderson, KC .

BLOOD, 2000, 96 (09) :2943-2950

[9] Molecular mechanisms of novel therapeutic approaches for multiple myeloma [J].

Hideshima, T ;

Anderson, KC .

NATURE REVIEWS CANCER, 2002, 2 (12) :927-937

[10]

Kisselv AF, 2001, CHEM BIOL, V21, P1

← 1 2 →